653 related articles for article (PubMed ID: 25027687)
21. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma.
Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S
Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360
[TBL] [Abstract][Full Text] [Related]
22. D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress.
Desch A; Gebhardt C; Utikal J; Schneider SW
Int J Cancer; 2017 Feb; 140(4):914-921. PubMed ID: 27813063
[TBL] [Abstract][Full Text] [Related]
23. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
[TBL] [Abstract][Full Text] [Related]
24. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
Komai Y; Saito K; Sakai K; Morimoto S
BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
[TBL] [Abstract][Full Text] [Related]
25. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
Brookman-Amissah S; Kendel F; Spivak I; Pflanz S; Roigas J; Klotz T; May M
BJU Int; 2009 May; 103(10):1375-80. PubMed ID: 19040527
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of p21-activated kinase 6 expression in patients with clear cell renal cell carcinoma.
Liu W; Liu H; Liu Y; Xu L; Zhang W; Zhu Y; Xu J; Gu J
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S575-83. PubMed ID: 24715215
[TBL] [Abstract][Full Text] [Related]
27. Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma.
Paly JJ; Hallemeier CL; Biggs PJ; Niemierko A; Roeder F; Martínez-Monge R; Whitson J; Calvo FA; Fastner G; Sedlmayer F; Wong WW; Ellis RJ; Haddock MG; Choo R; Shipley WU; Zietman AL; Efstathiou JA
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):618-23. PubMed ID: 24411190
[TBL] [Abstract][Full Text] [Related]
28. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma.
Xia Y; Liu L; Long Q; Bai Q; Wang J; Xu J; Guo J
Urol Oncol; 2016 Jan; 34(1):5.e1-9. PubMed ID: 26411550
[TBL] [Abstract][Full Text] [Related]
30. Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma.
Pichler M; Dalpiaz O; Ehrlich GC; Stojakovic T; Martín Hernández JM; Mannweiler S; Pummer K; Zigeuner R; Hutterer GC
J Urol; 2014 Apr; 191(4):920-5. PubMed ID: 24513163
[TBL] [Abstract][Full Text] [Related]
31. A Novel Predictor of Survival with Renal Cell Carcinoma After Nephrectomy.
Peng D; He ZS; Li XS; Tang Q; Zhang L; Yang KW; Yu XT; Zhang CJ; Zhou LQ
J Endourol; 2017 Apr; 31(4):397-404. PubMed ID: 28121179
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
[TBL] [Abstract][Full Text] [Related]
33. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
Tilki D; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
Eur Urol; 2014 Sep; 66(3):577-83. PubMed ID: 23871402
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of preoperative serum total cholesterol in patients with clear cell renal cell carcinoma.
Ohno Y; Nakashima J; Nakagami Y; Gondo T; Ohori M; Hatano T; Tachibana M
Urology; 2014 Jan; 83(1):154-8. PubMed ID: 24149106
[TBL] [Abstract][Full Text] [Related]
35. The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection.
Katz MD; Serrano MF; Humphrey PA; Grubb RL; Skolarus TA; Gao F; Kibel AS
Urol Oncol; 2011; 29(6):738-44. PubMed ID: 19914106
[TBL] [Abstract][Full Text] [Related]
36. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.
Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC
Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
[TBL] [Abstract][Full Text] [Related]
38. Association of Preoperative Plasma D-dimmer and Fibrinogen and Renal Cell Carcinoma Outcome.
He X; Huang T; Xue Y; Zhang M; Liu Q; Wang Y; Yao K; Guo S
J Cancer; 2019; 10(17):4096-4105. PubMed ID: 31417654
[No Abstract] [Full Text] [Related]
39. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
[TBL] [Abstract][Full Text] [Related]
40. The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
Bezan A; Mrsic E; Krieger D; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
J Urol; 2015 Jul; 194(1):30-5. PubMed ID: 25623738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]